UCSF

Tagged: Bioinformatics (Biological and Medical Informatics Graduate Program)

Update from the Dean - Fall/Winter 2010

Research: 30th anniversary as the nation's top National Institutes of Health-funded pharmacy school, Lightwood, Mandell, Kortemme, Coutsias, Keiser, Shoichet, Irwin, Laggner, Hert, Thomas, Edwards, Voigt, Levskaya, Lim, Weiner, Craik, Darragh, Schneider, Farady, Lou, Marks, Phojanakong, Hann....

Symposium on the future of therapeutics inaugurates new UCSF department

In the first symposium held by the newly minted UCSF Department of Bioengineering and Therapeutic Sciences, researchers described progress in the fields of systems biology, pharmacogenomics, and bioengineering, and how scientists in these fields are working in concert to develop novel diagnostics an

Shoichet research one of top breakthroughs for 2009

Wired Science has cited a computational model developed in the UCSF School of Pharmacy under the direction of faculty member Brian Shoichet, PhD, and applied and tested by scientists at the University of North Carolina at Chapel Hill School of Medicine, as one

Method to predict polypharmacology developed in Shoichet Lab

A computational method developed in the UCSF School of Pharmacy under the direction of faculty member Brian Shoichet, PhD, has the potential to predict new target diseases for existing drugs as well as unexpected side effects of approved drugs.

UCSF innovation among top 10 for 2009

The Scientist has cited a UCSF innovation among its top 10 list of tools to hit the life sciences in 2009. In the spotlight is a paper that reveals how to import plant "light switches" into mammalian cells to control complex regulatory processes. The paper appeared in the October 15, 2009 issue of...

Craik to lead Takeda-sponsored research on antibodies

Takeda San Francisco, Inc., announced September 21, 2009 that it has entered into a sponsored collaboration with UCSF to support antibody-related research in the laboratory of Charles S.

New drug targeted for Kaposi’s sarcoma

A team of scientists from UCSF and colleagues have identified a new potential drug target for the herpes virus that causes Kaposi’s sarcoma. Their research reopens the possibility of using a class of drugs called protease inhibitors, against diseases ranging from cancer to Alzheimer's Disease.

Update from the Dean - Spring/Summer 2009

New chancellor: Desmond-Hellman; budget update: 4% to 10% salary cuts via furloughs, possibly to be renewed; risk of poison control system closure; new Department of Bioengineering and Therapeutic Sciences; faculty honors and awards: Burchard, Peck, Desai, Roy, Bero, MacDougall, Hessol, Phillips,...

Voigt and Tabor talk synthetic biology on TV

Synthetic biologist and UCSF School of Pharmacy faculty member Christopher Voigt, PhD, and Jeffrey Tabor, a postdoctoral scholar in Voigt's laboratory, discuss the field and promise of synthetic biology in this July 21, 2009 KQED television se

Pages